Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Fastenal Tops Expectations in Q2, Stock Shoots Higher

Winona, Minn.-based Fastenal (FAST) reported very positive earnings numbers Thursday morning, which has spiked the company’s stock by nearly 5 percent in early trading. Growth for Fastenal has been … well, fast, and the report from the company reflects as much.

Fastenal Company (NASDAQ:FAST)

The stock is up to nearly $42 per share in the early moments of trading after reporting Q2 earnings per share of 38 cents, which beat predictions by 1 cent, and revenue of $805 million was $2 million better than expected and showed a 15 percent growth year-over-year. The company reported in its press release that its more than 2,400 stores had posted double-digit sales increases every month of 2012 compared to the same month in 2011 – capped by June’s 14 percent sales increase over June 2011 sales totals. Net profit for the company was reported at more than $112 million, a 19-percent jump, despite including losses on sales of some assets. This marked the third consecutive quarter of growth for the company.  The company opened 53 new stores in the first half of 2012, down from the mid-70s during the same period of 2011.

The company held a conference call Thursday morning to discuss the report, and that can be accessed at

There is much to be excited about with Fastenal’s report, and hedge funds like Louis Navellier’s Navellier & Associates and David Stemerman’s Conatus Capital Management should benefit greatly from this report. Navellier had staked nearly $53 million in the company at the end of the March, and Conatus was in for about $54 million after selling 46 percent of its holdings during the quarter. Timothy S. Peterson’s Regiment Capital had a $78.5 million put on the stock at the end of March, while Bart Baum’s Ionic Capital Management posted a $44 million call order at the same time.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!